DrugPatentWatch Database Preview

OSPHENA Drug Profile

« Back to Dashboard

When do Osphena patents expire, and what generic alternatives are available?

Osphena is a drug marketed by Duchesnay and is included in one NDA. There are eight patents protecting this drug.

This drug has ninety-two patent family members in thirty-one countries.

The generic ingredient in OSPHENA is ospemifene. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ospemifene profile page.

Summary for OSPHENA

International Patents:	92
US Patents:	8
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	43
Clinical Trials:	2
Patent Applications:	41
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for OSPHENA
Prior Art and Litigation Support	Order Prior Art and Litigation support for OSPHENA
DailyMed Link:	OSPHENA at DailyMed

Generic Entry Opportunity Date for OSPHENA

NDA:

203505

Dosage:

TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for OSPHENA

Drug Class	Estrogen Agonist/Antagonist
Mechanism of Action	Selective Estrogen Receptor Modulators

Synonyms for OSPHENA

(Z)-2-(4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy)ethan-1-ol

128607-22-7

2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol

2-(p-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol

2-[4-[(Z)-4-chloro-1,2-di(phenyl)but-1-enyl]phenoxy]ethanol

2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol

2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}ethanol

2617AH

AC-27645

AC1MI19T

AKOS025401964

B0P231ILBK

BCP20981

C24H23ClO2

CCRIS 9205

CHEBI:73275

CHEMBL2105395

CS-5961

D08958

DB04938

Deamino-hydroxytoremifene

Deaminohydroxytoremifene

Deaminotoremifene

Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-

Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-butenyl]phenoxy]-

Ethanol,2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-

Fc-1271

FC-1271a

GTPL7349

HSDB 8281

HY-B0723

J-005613

LUMKNAVTFCDUIE-VHXPQNKSSA-N

MolPort-006-170-032

O0441

Ophena

Ospemifene

Ospemifene (INN/USAN/BAN)

Ospemifene [USAN:INN:BAN]

Osphena (TN)

s4285

SCHEMBL948118

senshio

SW219657-1

UNII-B0P231ILBK

Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethanol

ZINC1550766

US Patents and Regulatory Information for OSPHENA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Duchesnay	OSPHENA	ospemifene	TABLET;ORAL	203505-001	Feb 26, 2013		RX	Yes	Yes
Duchesnay	OSPHENA	ospemifene	TABLET;ORAL	203505-001	Feb 26, 2013		RX	Yes	Yes
Duchesnay	OSPHENA	ospemifene	TABLET;ORAL	203505-001	Feb 26, 2013		RX	Yes	Yes
Duchesnay	OSPHENA	ospemifene	TABLET;ORAL	203505-001	Feb 26, 2013		RX	Yes	Yes

International Patents for OSPHENA

Country	Patent Number	Estimated Expiration
Russian Federation	2423113
Norway	337656
Norway	339190
Cyprus	1111689

Supplementary Protection Certificates for OSPHENA

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1713458	PA2015023	Lithuania		PRODUCT NAME: OSPEMIFENUM; REGISTRATION NO/DATE: EU/1/14/978/001, 2015 01 15 EU/1/14/978/002 20150115
1713458	1590030-1	Sweden		PRODUCT NAME: OSPEMIFENE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/14/978/001 20150119
1713458	PA2015023,C1713458	Lithuania		PRODUCT NAME: OSPEMIFENAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/14/978/001, 2015 01 15 EU/1/14/978/002 20150115
1713458	C20150029 00165	Estonia		PRODUCT NAME: OSPEMIFEEN;REG NO/DATE: EU/1/14/978 19.01.2015